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LETTER TO THE EDITOR
Proliferative lesions in the livers of mice treated 18 months previously
with cisplatin
Sir -- Cis-diammine-dichloroplatinum II ('cisplatin') is a
widely used cytotoxic agent that is known to cause long-term
renal insufficiency. Bulger and Dobyan (1984) and Dobyan
(1985) have reported hyperplastic lesions in the kidneys of
rats treated 6 and 15 months previously with a single
intraperitoneal dose of 6mgkg-1 of cisplatin. These authors
queried whether this drug might not be mutagenic and
carcinogenic.
In this laboratory, long-term studies on the effects of
cisplatin on renal structure have recently shown incidental
findings of dysplasia in the livers of mice treated by
cisplatin. B6D2F1 adult male mice (C57B16 x DBA2;
Paterson Institute strain) were injected intravenously with
single bolus doses of 8-I5mgkg-1. Animals surviving the
period of acute toxicity were sacrificed 18 months later.
Fifteen of fifty treated mice (30%) showed abnormal
pathology. Two had gross renal disease, one an enlarged
spleen and a squamous cell carcinoma of the skin, and one a
lymphoma. The remaining 11 mice had lesions confined to
the liver. A spectrum of change was seen, ranging from a
diffuse, mottled appearance to a gross enlargement of one or
more lobes.
Histopathological examination revealed three main
categories of change:
(i) A diffuse change with tracts of atypical or dysplastic
liver cells that in places linked up to enclose islands of
normal hepatocytes (Figure IA).
(ii) Non-encapsulated nodules of mildly-dysplastic liver
cells, often with frequent mitoses. In such cases,
sinusoidal architecture was retained (Figure 1B).
(iii) Non-encapsulated nodules of large, very atypical
hepatocytes with deranged sinusoidal architecture.
Again, mitoses were frequent (Figure IC,D).
Other features present in some nodules were: coarse, fatty
vacuolation; cytoplasmic 'inclusions' in nuclei; large
eosinophilic bodies in the cytoplasm; and dilation of
sinusoids and blood vessels resembling peliosis (Figure IC).
Within this ongoing series of experiments no such changes
have been seen in 28 age-matched mice that had received X-
rays to one kidney, nor in the 8 untreated control animals
sacrificed to date.
Stage (iii) changes in cisplatin-treated mice resemble
human hepatocellular carcinoma, and transplantation into
isogenic mice to test for tumour formation is now under
way. Extrapolation of rodent data to man must be viewed
with great caution but these preliminary observations,
together with those of Bulger and Dobyan (1984) and
Kempf and Ivankovic (1986a,b; who found frank leukaemias
in rats treated by repeated intraperitoneal doses of cisplatin)
suggest that there might be a long-term risk of proliferative,
and possibly malignant, lesions arising in a number of
normal tissues after treatment by cisplatin.
Yours etc.,
C. Ewen', J.V. Moore' & M. Harris2
'Paterson Institute for Cancer Research and
2Department of Pathology, Christie Hospital
and Holt Radium Institute,
Manchester M20 9BX, UK.
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Figure 1 Photomicrographs of haematoxylin and eosin-stained, thin sections of livers from mice treated 18 months earlier with
cisplatin. (A) Tract of atypical (a) cells partially enclosing island of normal (n) hepatocytes, ( x 90); (B) Nodule of mildly dysplastic
liver cells, with numerous mitoses (m), ( x 147); (C) Interior of nodule of large, atypical hepatocytes, some in mitosis (m), ( x 141);
(D) Edge of nodule from (C), showing compression of adjacent tissue (t), ( x 90).